Introduction: The Shift Toward Direct U.S. Import Control

Navigating the entry of commercial cargo into the United States is a complex regulatory undertaking. When imported merchandise falls under the jurisdiction of the U.S. Food and Drug Administration (FDA) in addition to U.S. Customs and Border Protection (CBP), the importer must coordinate customs, regulatory, documentation, product, and supply-chain requirements simultaneously.

Traditionally, many foreign manufacturers have relied on U.S. distributors, wholesalers, retailers, or other domestic buyers to manage the importation process. Under this arrangement, the U.S. customer may act as the Importer of Record (IOR) and assume responsibility for the customs entry. This model can work effectively, but it also gives the U.S. customer substantial control over how products enter the country.

If that buyer changes suppliers, encounters financial difficulties, refuses future importing responsibilities, changes its customs broker, or terminates the commercial relationship, the foreign manufacturer's access to the U.S. market can be disrupted. A manufacturer may suddenly have inventory ready for shipment but no customer willing to accept the responsibilities associated with customs entry.

Requiring every new U.S. customer to become an importer can also restrict business development. Many retailers, e-commerce sellers, regional distributors, medical practices, specialty stores, restaurants, and other customers want to purchase products domestically without assuming customs responsibilities.

For this reason, some foreign manufacturers and exporters investigate whether they can become their own U.S. Importer of Record, either through a properly structured non-resident importer arrangement or through a U.S. business entity. When implemented correctly, the strategy can transform the foreign company from a vendor dependent on individual U.S. importers into a supplier capable of coordinating its own import transactions.

However, becoming an IOR does not eliminate regulatory responsibilities. Instead, it transfers additional responsibilities to the company controlling the import transaction. Customs classification, valuation, country-of-origin requirements, customs bonds, FDA admissibility, facility registration, product listing, Prior Notice, FSVP, labeling, recordkeeping, detention response, and other requirements may apply depending on the product.

The objective is therefore not simply to obtain an importer number. The objective is to build a complete and sustainable U.S. import compliance infrastructure.

Chapter 1: Understanding the Dual Responsibility — CBP and FDA

A foreign company preparing to control its own importation must first understand the distinction between customs responsibilities and FDA responsibilities. Although the agencies cooperate at the border, they have different regulatory missions.

The CBP Perspective: Customs and Entry Accountability

U.S. Customs and Border Protection administers the customs entry process, collects duties and applicable fees, enforces tariff and trade laws, and participates in cargo security enforcement. The Importer of Record generally has responsibility for exercising reasonable care in the information presented to CBP.

Responsibilities can include:

• Providing accurate commercial entry information.
• Using the appropriate Harmonized Tariff Schedule classification.
• Reporting the correct customs value.
• Identifying the proper country of origin.
• Paying applicable duties, taxes, and fees.
• Maintaining required import records.
• Responding to customs inquiries and requests for information.
• Maintaining an adequate customs bond when required.

The FDA Perspective: Product Admissibility and Public Health

FDA's concern is different. The agency evaluates whether regulated products offered for import comply with applicable requirements of the Federal Food, Drug, and Cosmetic Act and other laws administered by FDA.

A shipment can therefore satisfy customs requirements while still encounter FDA compliance problems. A product may have the correct tariff classification and customs value but still be detained because of labeling, registration, listing, safety, manufacturing, Prior Notice, or other regulatory concerns.

Chapter 2: Operational Steps for Establishing an Importer of Record Structure

A foreign exporter generally should not assume that placing its company name on a commercial invoice is sufficient to become an Importer of Record. The importer structure must be established before shipments arrive.

Working with Customs Brokers and Express Couriers

A licensed customs broker can be an essential operational partner for a foreign company importing into the United States. The broker can prepare customs entries based on information supplied by the importer, transmit entry data through CBP systems, coordinate customs releases, and communicate when additional documentation is required.

Large international couriers such as FedEx, UPS, and DHL also operate brokerage systems for qualifying shipments. However, using a courier does not eliminate the importer's responsibility for accurate information. The importer should establish its account, importer number, authorization, bond, FDA information, and product documentation before relying on routine express shipments.

Chapter 3: Customs Bonds, Classification, Valuation and Entry Documentation

A company becoming its own Importer of Record assumes greater responsibility for the information supplied to the customs broker. A broker can assist with entry preparation, but the importer should maintain internal procedures for reviewing the underlying commercial information.

Continuous Customs Bonds

Companies importing frequently may use a continuous customs bond covering multiple entries during the bond period. Bond sufficiency should be monitored as import volume changes. The appropriate bond amount can depend on the importer's transaction profile, duties, taxes, fees and other risk factors.

Importers should not treat the bond as merely another shipping fee. A bond is a financial guarantee associated with customs obligations. If the import program grows rapidly, the company should periodically review whether its bond remains adequate.

Chapter 4: FDA Registration, U.S. Agents and Product-Specific Requirements

Customs readiness is only the beginning for FDA-regulated merchandise. Different product categories are subject to different FDA regulatory frameworks. A company importing several categories should avoid assuming that one FDA registration covers every product.

The FDA U.S. Agent

Foreign establishments subject to an FDA U.S. Agent requirement must designate an appropriate U.S.-based representative. The FDA U.S. Agent role should not be confused with the customs broker, Importer of Record, FSVP importer, Initial Importer, consignee, distributor, or freight forwarder.

A single organization may perform more than one function when legally appropriate, but each role carries separate responsibilities. Companies should therefore identify each party in the transaction and document exactly which regulatory function that party is performing.

Chapter 5: Prior Notice for Imported Food Shipments

Food shipments entering the United States generally require FDA Prior Notice before arrival. Prior Notice provides FDA with advance information concerning food offered for import so that the agency can evaluate the shipment before it reaches the port.

The filing should contain accurate information about the product, manufacturer, shipper, country, arrival information and other required data. Errors can create delays even when the underlying product is otherwise compliant.

A company acting as its own IOR should establish a written procedure defining who is responsible for Prior Notice. Depending on the logistics arrangement, the filing may be coordinated by the customs broker, freight forwarder, shipper or another qualified party.

Chapter 6: Foreign Supplier Verification Program (FSVP)

For imported foods subject to the Foreign Supplier Verification Program, becoming the customs Importer of Record does not automatically satisfy the FSVP requirement. The identity of the customs importer and the identity of the FSVP importer must be evaluated separately.

FSVP was established under the Food Safety Modernization Act to place responsibility on qualifying U.S.-based importers to verify that foreign suppliers produce food using processes and procedures that provide the required level of public-health protection.

A Foreign Company May Need a U.S.-Based FSVP Importer

A foreign manufacturer operating outside the United States may be able to establish a customs import structure, but that does not necessarily mean the foreign entity can act as the FSVP importer. When no qualifying U.S. owner or consignee exists at the time of entry, a properly designated U.S. agent or representative may be required for FSVP purposes, subject to the applicable regulatory conditions.

This distinction is particularly important for companies shipping directly to Amazon fulfillment centers, third-party logistics warehouses, e-commerce fulfillment companies, or customers that do not want to accept FSVP responsibility.

Building an FSVP Compliance File

An FSVP program should be more than a name and telephone number placed on an entry. Depending on the product and regulatory circumstances, the program can involve supplier evaluation, hazard analysis, verification activities, corrective actions, reassessment and recordkeeping.

Chapter 7: FDA-Compliant Labeling Before Importation

One of the most avoidable causes of import problems is shipping products before completing a U.S. label review. A label acceptable in Europe, Asia, Latin America, Africa, Canada, Australia, or another market is not automatically compliant with U.S. FDA requirements.

The U.S. label should be evaluated before commercial production and before inventory is dispatched. Waiting until merchandise reaches a U.S. warehouse can make corrections considerably more expensive.

OTC drugs require a different labeling framework, including Drug Facts and other mandatory information. Medical devices and cosmetics have their own labeling requirements. The correct review therefore depends on the legal classification of the product.

Chapter 8: Importing Directly to Amazon and U.S. Fulfillment Warehouses

The growth of e-commerce has made the Importer of Record question particularly important for foreign brands. A company may want to manufacture overseas and ship inventory directly to an Amazon fulfillment center or another U.S. third-party logistics warehouse.

A warehouse receiving the goods should not automatically be assumed to be the Importer of Record, FSVP importer, FDA U.S. Agent, medical device Initial Importer, or regulatory representative. These roles should be established before the shipment leaves the country of export.

For an e-commerce shipment, the foreign company should coordinate the customs broker, carrier, customs bond, IOR information, FDA requirements, FSVP information where applicable, warehouse delivery instructions and final-mile appointment requirements.

This becomes particularly important when inventory is shipped by ocean freight or air freight in commercial quantities. If a shipment is held because the importer information is incomplete, storage and demurrage expenses can accumulate while the company attempts to resolve regulatory issues.

Why Controlling the IOR Can Support E-Commerce Expansion

When properly structured, direct control of importation can allow a foreign brand to replenish multiple U.S. fulfillment locations without asking each marketplace customer or retail buyer to become the customs importer. The company can develop one repeatable import process and use it to support wholesale, direct-to-consumer and marketplace distribution.

Chapter 9: FDA Holds, Detentions and Import Refusals

Even a carefully structured importer can encounter an FDA examination or hold. The critical difference is preparedness. A company controlling its import program should know who receives FDA communications, who communicates with the customs broker, where regulatory records are stored and who has authority to respond.

FDA may review an imported shipment based on product type, manufacturer history, country, entry information, compliance concerns, sampling priorities, Import Alert considerations or other regulatory factors. The agency may request documents, examine merchandise, collect samples or take other appropriate action.

When a shipment is detained, the company should immediately identify the reason for the detention and the deadline for responding. Depending on the circumstances, supporting evidence may involve registration information, product records, labeling, laboratory results, manufacturing information, supplier records, corrective actions or other documentation.

Chapter 10: Recordkeeping and Internal Import Compliance Procedures

A scalable import program requires records that can be retrieved quickly. Documents should not remain scattered across the email accounts of employees, freight forwarders, suppliers and brokers.

The company should create a centralized import compliance file for each product and supplier. Depending on the product, this can include customs classification records, commercial invoices, FDA registrations, product listings, label reviews, FSVP records, Prior Notice confirmations, laboratory reports, supplier certifications and correspondence.

Chapter 11: Benefits of Becoming Your Own Importer of Record

The principal advantage of an importer-controlled structure is independence. Instead of asking each U.S. customer to manage the border transaction, the foreign company can potentially deliver merchandise after the import process has been coordinated through its own established infrastructure.

Chapter 12: Common Mistakes Foreign Companies Should Avoid

Foreign companies frequently underestimate the distinction between shipping products internationally and legally importing FDA-regulated commercial goods into the United States. A parcel successfully delivered by an international courier does not establish that the company has built a compliant long-term commercial import program.

One common mistake is allowing different parties to use inconsistent importer information. The commercial invoice may identify one company, the customs broker may have another importer number, the FDA entry may identify a different manufacturer, and the FSVP information may point to an entity that has never agreed to assume the role. These inconsistencies can create questions during entry review.

Another mistake is registering a facility but ignoring product-level compliance. FDA registration generally should not be interpreted as FDA approval of the company or its products. Registration does not replace labeling compliance, applicable product listings, FSVP, Prior Notice, food safety requirements, drug requirements, medical device requirements, or other obligations.

Companies also sometimes ship first and attempt to correct the label after arrival. This strategy can become costly when thousands of units are already inside a port, bonded warehouse or fulfillment network.

Finally, a foreign exporter should not assume that the customs broker is automatically responsible for every FDA requirement. Brokers perform a critical customs function, but regulatory responsibilities should be assigned and documented separately.

Chapter 13: Building a Pre-Shipment Compliance Checklist

Before each commercial shipment, the importer should use a repeatable pre-shipment checklist. The objective is to identify missing information while the merchandise is still at the foreign facility rather than after it reaches a U.S. port.

Conclusion: Building a Resilient U.S. Import Infrastructure

Becoming your own U.S. Importer of Record for FDA-regulated products can provide foreign manufacturers and exporters with substantially greater control over their U.S. supply chains. It can reduce dependence on individual distributors, improve access to customers that do not want to become importers, and support direct distribution through U.S. warehouses, e-commerce platforms and fulfillment networks.

However, an Importer of Record strategy should be viewed as a compliance infrastructure project rather than a simple customs registration exercise. The importer must coordinate customs identity, broker authorization, bonds, classification, valuation, shipping documentation and recordkeeping while simultaneously addressing the FDA requirements applicable to the product.

For food and dietary supplements, those requirements may include Food Facility Registration, U.S. Agent designation, Prior Notice, FSVP, labeling and food safety documentation. Medical devices can involve establishment registration, device listing, U.S. Agent and Initial Importer responsibilities. Cosmetics and drugs operate under additional regulatory frameworks that must be reviewed separately.

Foreign companies from Europe, Asia, Latin America, Africa and other regions should therefore establish their import structure before shipping commercial inventory. The appropriate customs broker, FDA consultant, logistics provider, FSVP representative and other responsible parties should understand their roles before the first entry arrives.

The strongest import programs are built around repeatable procedures. Each shipment should follow the same controlled sequence: verify the product, confirm the manufacturer, validate FDA requirements, review the label, identify the correct importer and regulatory parties, prepare commercial documentation, complete applicable pre-arrival filings and maintain the final entry records.

With that infrastructure in place, the foreign manufacturer is no longer dependent on improvising a new import solution for every customer or every shipment. Instead, the company can develop a scalable U.S. market strategy supported by a consistent customs and FDA compliance framework.